SMAD3 and neoplasm: Interestingly, SB431542 treatment as indicated time had no effect on this interaction, but aggravated this inhibition effect of miR-1 mimics (Figure 3s), In summary, these data suggested that Smad3 is the primary regulator of miR-1-induced inhibition of tumor glycolysis.